title: Two remarkable dyspneic men: when should terminal sedation be administered?
authors.affiliation: University of Alberta, Edmonton, Alberta, Canada.
authors.forename: Kathryn
authors.initials: K
authors.lastname: Lanuke
authors.forename: Robin L
authors.initials: RL
authors.lastname: Fainsinger
authors.forename: Donna
authors.initials: D
authors.lastname: DeMoissac
authors.forename: James
authors.initials: J
authors.lastname: Archibald
mesh_terms: D002282:Adenocarcinoma, Bronchiolo-Alveolar / Q000503:physiopathology; D000368:Aged; D004417:Dyspnea / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage*; D008175:Lung Neoplasms / Q000503:physiopathology; D008297:Male; D018447:Medical Futility; D008875:Middle Aged; D010166:Palliative Care / Q000941:ethics / Q000592:standards*; D026684:Personal Autonomy; D011658:Pulmonary Fibrosis / Q000503:physiopathology; D013727:Terminal Care / Q000941:ethics / Q000592:standards*
chemical_list: D006993:Hypnotics and Sedatives